Építés alatt – nem éles oldal
Belépés
LeállítvaFázis nélkül

Study of the Braive Growth Modulation System for Progressive Pediatric Scoliosis

A legfontosabb adatok

Ki végzi
Medtronic Spinal and Biologics
Hol
Rochester (Egyesült Államok)A helyszín megnézéseMég 2 másik országban, 3 helyszínen
Azonosító
Állapot
Leállítva
Résztvevők
10 fő vett részt
Kezdés
2021. aug. 12.
Befejezés
2026. jan. 14.
A vizsgálat típusa
Beavatkozással járó
A vizsgált kezelések
  • Braive™ Growth Modulation System (Braive™ GMS)
A regiszteradat frissítve
2026. október 28.
Miért állt le
The decision to early terminate the study was taken based on the achievement of all primary endpoints at 24-month for every active subjects. In addition, there are currently no plans to use the collected data to seek regulatory approval.

Ki vehet részt

Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 27 feltétel megnézéseKevesebb

Ki vehet részt

  • A subject must meet all of the following inclusion criteria to participate in this study:
  • Has a diagnosis of juvenile or adolescent idiopathic scoliosis
  • Is skeletally immature with a Sanders Score of ≥2 to ≤5
  • Has failed conservative care as per investigator's assessment
  • Has a main thoracic Cobb angle between 30 and 60 degrees
  • Has a Lenke Classification of 1A, 1B, or 1C
  • Has kyphosis ≤ 40 degrees with a sagittal thoracic modifier N or negative
  • Informed Consent Form/Assent and Authorization to Use and Disclose Health Information (if applicable) have been signed by Parent/legal guardian and/or patient/participant per local requirement

Ki nem vehet részt

  • Has undergone previous spinal fusion procedure(s) at the affected levels
  • Has had prior ipsilateral or contralateral chest surgery
  • Concurrent participation in another clinical study that may add additional safety risks and/or confound study results
  • Has an associated syndrome
  • Has a history of malignant hyperthermia
  • Has an active or significant risk of infection (immunocompromised)
  • Has a suspected or documented allergy or intolerance to implant materials
  • Has a major psychiatric disorder / history of drug abuse that would interfere with the subject's ability to comply with study instructions or might confound the study interpretation as per investigator's assessment (DSM-5 can be used as a reference)
  • Has severe chronic lung disease (e.g., asthma, bronchiectasis)
  • A subject will be excluded from participating in this study for any of the following reasons:
  • Is pregnant or plans to become pregnant within the first 24-months of the study
  • Has a curve that requires instrumentation below L1
  • Has spinal MRI abnormalities (e.g., CHIARI malformation, Syrinx greater than 4mm, tethered cord)
  • Has any type of non-idiopathic scoliosis
  • Has a left-sided curve
  • Has inadequate tissue coverage over the operative site as per investigator's assessment
  • Is a ward of the court/state
  • Has poor bone quality, as determined by the investigator, that may limit anterior fixation
  • Is unwilling or unable to return for follow-up visits and/or follow intra-operative and/or postoperative instructions

Helyszínek itt: Egyesült Államok

Még 2 másik országban, 3 helyszínen

  • Mayo ClinicRochester, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

The purpose of this study was to establish probable benefits and evaluate the safety and preliminary effectiveness of the Braive™ GMS when used in the treatment of pediatric progressive scoliosis.

A vizsgálat csoportja

  • Braive™ Growth Modulation System (Braive™ GMS)A vizsgált kezelés

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
A Prospective, Multi-Center Study of the Braive™ Growth Modulation System When Used in the Treatment of Pediatric Patients Diagnosed With Juvenile or Adolescent Idiopathic Scoliosis
A regiszteradat frissítve
2026. október 28.